About Forbion
Forbion is a leading global venture capital firm with deep expertise in Europe and offices in Naarden (Netherlands), Munich (Germany), and Boston (USA). We invest in innovative biotech companies, managing approximately €5 billion across multiple fund strategies that cover all stages of (bio-)pharmaceutical drug development. In addition, Forbion leverages its biotech expertise beyond human health to address ‘planetary health’ challenges through its BioEconomy fund, investing in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies. Since the inception 20 years ago, our team of approximately 70 professionals, representing 14...
Leadership at Forbion
The team at the top of the org chart.
Holger Reithinger
Senior Advisor
1 report
Patrick Vink
Operating Partner
Peter Høngaard Andersen
Operating Partner
Sander Van Deventer
Operating Partner
John Montana
Operating Partner
John J.p. Kastelein
Operating Partner
Philip Astley-Sparke
Venture Partner
Matt Cooper
Venture Partner
Michael Hayden
Venture Partner
Philip Astley-Sparke
Venture Partner
Patrick Round
Venture Partner
Ton Logtenberg
Venture Partner
Joy Faucher
Partner
Rogier Rooswinkel
Partner
2 reports
Mathias Vinther
Principal
Robbert Van De Griendt
Head, Investor Relations, ESG & Impact
9 reports
Sander Slootweg
Managing Partner
44 reports
Martien Van Osch
Managing Partner
Geert-Jan Mulder
Managing Partner
Danielle de Magalhaes
Executive Assistant
Machteld Groeneveld
Chief Legal, Risk & Compliance Officer
2 reports
Tineke Duijn
Office Management
2 reports
James Rush
Venture Partner
Jennifer Fritzsche
Senior Controller
Pascal van Wees
Finance Director
Stijn Jochemsen
Finance Director
Stan Nelissen
Interim Controller
2 reports
Walter Schram
Finance Director
Wim Das
Managing Partner CLSF / Investor In Forbion Growth Fund
Board
William Sandborn
Advisor
Alexander Eggermont
Advisor
Scott Friedman
Advisor
John Ford
Advisor
Yigal M. Pinto
Advisor
Frank G. Holz
Advisor